Top Markets
#1 Cortex Cortex +173.88%
#2 Helium Helium +62.97%
#3 GEKKO GEKKO +52.86%
#4 Pons Pons +24.66%
#5 ADO Protocol ADO Protocol +18.06%
#6 o1.exchange o1.exchange +15.46%
#7 COTI COTI +11.47%
#8 Status Status +11.13%
#9 Collect on Fanable Collect on Fanable +10.99%
#10 Siren Siren +10.93%
Coin of the day
Cortex Cortex
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Sopharma AD Sopharma AD

Sopharma AD

SPH
Kedudukan dalam Saham #8637
Sopharma AD, an international pharmaceutical company founded in Sofia,... Sopharma AD, an international pharmaceutical company founded in Sofia, Bulgaria, in 1933, specializes in the research, development, manufacturing, and commercialization of a wide array of healthcare products. Its offerings span medicinal substances, finished drug formulations, veterinary vaccines, infusion solutions, and disposable plastic medical devices for both human and animal health, in addition to food supplements. The company's diverse product portfolio addresses numerous therapeutic categories, including cardiology, gastroenterology, pain management, cough and cold remedies, immunology and dermatology, respiratory conditions (like asthma), neurology and psychiatry, urology, and gynecology. Key products include Carsil for gastrointestinal issues, the analgesic Tempalgin, Tabex for smoking cessation, Tribestan to support sexual system functions, Broncholytin for coughs, the common pain reliever Analgin, Nivalin for peripheral nervous system disorders, and Methylprednisolon for severe allergies and critical medical situations. Beyond its core pharmaceutical business, Sopharma AD engages in a variety of other ventures. These include providing secondary packaging services for pharmaceuticals, leasing real estate, and operating in the retail sector for medicines and medical equipment. The company also handles the cultivation, collection, and trade of herbs and medicinal plants. Furthermore, it is involved in the trading, transport, and packaging of radioactive materials and nuclear equipment for medical applications, as well as household electronics and electrical equipment. Sopharma AD also offers market and public opinion research, provides franchising and know-how, and participates in various consulting and non-pharmaceutical activities, such as the production of veterinary vaccines and infusion solutions.
Harga Saham
$2.28
Disegerakkan terakhir: 2026-08-27
Modal Pasaran
$1.20B
Perubahan (1 hari)
2.53%
Perubahan (1 tahun)
-34.74%
Negara
BG
Perdagangan Sopharma AD (SPH)

Kategori

Healthcare
Nisbah P/E bagi Sopharma AD (SPH)
Nisbah P/E pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Sopharma AD, nisbah P/E semasa (TTM) ialah 0. Pada akhir 2026, syarikat mempunyai nisbah P/E sebanyak 0.
Sejarah nisbah P/E bagi Sopharma AD dari 2026 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
McKesson Corporation McKesson Corporation
McKesson Corporation
MCK.US
 23.15 -
US
Cencora, Inc. Cencora, Inc.
Cencora, Inc.
COR.US
 - -
US
Cardinal Health, Inc. Cardinal Health, Inc.
Cardinal Health, Inc.
CAH.US
 32.35 -
US
AmerisourceBergen Corporation AmerisourceBergen Corporation
AmerisourceBergen Corporation
ABC.US
 - -
US
Sigma Healthcare Limited Sigma Healthcare Limited
Sigma Healthcare Limited
SIG.AX
 -338.64 -
AU
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.